From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

Physician's First Watch

Like this article?
Get free daily
medical news from Physician's First Watch.

Manufacture of Oral Agent for Gonorrhea Resumes

The only CDC-recommended oral treatment for gonorrhea is available for the first time since 2002, when Wyeth Pharmaceuticals stopped making it.

According to a report in MMWR, Lupin Pharmaceuticals has resumed production of the drug, cefixime (Suprax). A single 400-mg tablet is suggested for uncomplicated gonorrhea infection.

Cefixime is the only recommended oral antimicrobial to which Neisseria gonorrhoeae has not developed resistance.

LINK(S):

MMWR article (Free)

MMWR article on cefixime discontinuation in 2002 (Free)

Published in Physician's First Watch April 25, 2008

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. Please consider this when composing your remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Article Tools

Reader Remarks

Sign-In

Forgot your password?

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2008. Massachusetts Medical Society. All rights reserved.